Cerity Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$117M Buy
263,692
+10,768
+4% +$4.79M 0.21% 100
2025
Q1
$123M Buy
252,924
+14,895
+6% +$7.22M 0.25% 85
2024
Q4
$97.5M Buy
238,029
+8,987
+4% +$3.68M 0.21% 98
2024
Q3
$107M Buy
229,042
+29,225
+15% +$13.6M 0.24% 90
2024
Q2
$93.7M Buy
199,817
+5,085
+3% +$2.38M 0.25% 81
2024
Q1
$81.4M Buy
194,732
+63,837
+49% +$26.7M 0.22% 102
2023
Q4
$53.3M Buy
130,895
+58,974
+82% +$24M 0.18% 128
2023
Q3
$25M Buy
71,921
+23,232
+48% +$8.08M 0.12% 165
2023
Q2
$17.1M Buy
48,689
+8,958
+23% +$3.15M 0.07% 254
2023
Q1
$16.3M Buy
39,731
+35,687
+882% +$14.6M 0.04% 274
2022
Q4
$1.17M Buy
4,044
+1,267
+46% +$366K 0.01% 653
2022
Q3
$804K Buy
2,777
+223
+9% +$64.6K 0.01% 565
2022
Q2
$720K Buy
2,554
+724
+40% +$204K 0.01% 633
2022
Q1
$478K Sell
1,830
-504
-22% -$132K 0.01% 604
2021
Q4
$515K Buy
2,334
+821
+54% +$181K 0.01% 587
2021
Q3
$274K Buy
1,513
+43
+3% +$7.79K 0.01% 585
2021
Q2
$296K Buy
1,470
+107
+8% +$21.5K 0.01% 583
2021
Q1
$293K Buy
1,363
+82
+6% +$17.6K 0.01% 561
2020
Q4
$303K Buy
1,281
+193
+18% +$45.7K 0.01% 516
2020
Q3
$296K Sell
1,088
-88
-7% -$23.9K 0.01% 410
2020
Q2
$341K Buy
1,176
+14
+1% +$4.06K 0.02% 333
2020
Q1
$276K Buy
1,162
+100
+9% +$23.8K 0.02% 356
2019
Q4
$233K Sell
1,062
-651
-38% -$143K 0.01% 474
2019
Q3
$290K Buy
1,713
+105
+7% +$17.8K 0.02% 401
2019
Q2
$295K Sell
1,608
-326
-17% -$59.8K 0.02% 402
2019
Q1
$356K Sell
1,934
-438
-18% -$80.6K 0.02% 383
2018
Q4
$393K Sell
2,372
-138
-5% -$22.9K 0.03% 356
2018
Q3
$484K Buy
2,510
+1,028
+69% +$198K 0.03% 338
2018
Q2
$252K Buy
+1,482
New +$252K 0.02% 461